MDSCs inhibit the immune-suppressive T cells in CT26 and other tumor types through various mechanisms such as high levels of arginase I (Arg), inducible nitric oxide synthase (iNOS), and others [57]. This evidence concerns the gene NOS2 and neoplasm.